The Significance of Artificial Intelligence-Guided Psychotherapy of Depression and Anxiety Disorders
Sponsor: Aleksandra Stojanovic
Trial Details
| Condition | Depression - Major Depressive Disorder, Anxiety Disorders |
| Intervention | AI-Guided Cognitive Behavioral Therapy; Cognitive Behavioral Therapy (CBT) |
| Phase | NA |
| Status | Recruiting |
| Participants | 120 |
| Est. Completion | 15 May 2026 |
| Last Updated | 8 May 2026 |
Primary Outcome
Change in depressive symptom severity; Change in anxiety symptom severity
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: Age 18 years or older Diagnosis of mild depressive disorder and/or anxiety disorder confirmed by a structured clinical interview (MINI) Ability to understand and provide informed consent Access to a device capable of using the digital platform (computer, tablet, or smartphone) Willingness to participate in weekly sessions over a 10-week period Exclusion Criteria: Moderate to severe depressive disorder Current or past diagnosis of psychotic disorder Bipolar disorder Substance use disorder or dependence Primary diagnosis of antisocial personality disorder Severe cognitive impairment or inability to use digital tools Acute suicidal risk requiring immediate intervention Concurrent participation in another structured psychotherapy program-
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service